CClinicalTrials.gg
Active, not recruitingNCT07766642Updated Aug 14, 2026

A Clinical Trial to Evaluate the Effects of a Supplement on Children's Focus and Energy

An interventional study of Auri Super Mushroom Daily Gummies For Kids in Difficulty Focusing, Poor Concentration and Poor Memory, sponsored by Auri Nutrition. Active, not recruiting at 1 site in United States. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2026-08-14.

Sponsored by Auri Nutrition · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Not applicable
Ages
4 Years to 12 Years
Sex
All
01

Study summary

This study will evaluate the effects of the Auri Super Mushroom Daily Gummies For Kids on focus and energy in children aged 4-12. The study is a single-arm, unblinded, virtual trial conducted over 8 weeks, in which all 35 enrolled participants will use the test product daily.

Parents of the participants will complete questionnaires at Baseline, Week 2, Week 4, Week 6, and Week 8 to assess perceived changes in their child's focus, attention, sleep quality, gut health, natural energy, and overall well-being. Participants will also undergo cognitive battery testing at Baseline, Week 4, and Week 8 to provide objective measurements of focus and cognitive performance.

02

Conditions studied

  • Difficulty Focusing
  • Poor Concentration
  • Poor Memory
  • Low Energy

Browse trials for

03

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Be male or female.
  • Be aged 4-12.
  • Parent(s) reporting that their child has been experiencing issues regarding any of the following for the past four weeks: Difficulty focusing, Poor concentration, or Poor memory.
  • Parent(s) who report that their child will be willing to complete cognitive assessments at regular intervals during the study.
  • Any child who is generally healthy - does not live with any uncontrolled chronic disease.
  • Parent(s) who are willing to follow the study protocol and support their child to complete all study actions.
  • Any child who has no planned changes to school schedule, sleep routines, or behavioral therapies during the study duration.
  • Anyone willing to refrain from introducing any new prescription medications, wellness products, supplements, or herbal remedies into their child's routine during the test period.
  • If the child has been taking any other products, supplements, or herbal remedies, they have been taking these consistently for at least three months.
  • Has had a stable diet and sleep schedule for at least four weeks prior to the study.
  • Enrolled in and currently attending school at baseline and for the duration of the study period.
  • Resides in the United States.

Exclusion criteria

Exclusion Criteria:

  • Any child with a neurodevelopmental condition or developmental delay, including autism spectrum disorder, intellectual disability, language disorder, uncontrolled anxiety or mood disorder, or dyslexia.
  • Previous diagnosis of Attention-deficit hyperactivity disorder (ADHD).
  • Any child currently undergoing any assessments for suspected neurodevelopmental conditions or developmental delay.
  • Any child diagnosed with epilepsy or a seizure disorder.
  • Any child diagnosed with a bleeding disorder.
  • Any child with any known allergies or hypersensitivities to any supplement product ingredients.
  • Any child with any chronic health conditions that could impact their participation in this study, such as cancer, mental health disorders, a history of serious illness in the last three months, or planned surgery during the study period.
  • Any parent or child currently testing, or planning on starting in the next eight weeks, a product for another research study.
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
35 participants (actual)

Study arms

  • Experimental
    Auri Super Mushroom Daily Gummies For Kids

    Dietary Supplement: Auri Super Mushroom Daily Gummies For Kids

Interventions

  • Dietary supplementAuri Super Mushroom Daily Gummies For Kids

    All participants receive two Auri Super Mushroom Daily Gummies once daily in the morning with their first meal of the day for 8 weeks.

05

What researchers measure

Primary outcomes

  1. Change in Focus

    Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

    Time frame: Baseline, Week 4, and Week 8

  2. Change in Cognitive Performance

    Assessed via cognitive battery testing (Polygons, Double Trouble, Feature Match, Paired Associates, Digit Span, Spatial Planning) and self-reported questionnaire

    Time frame: Baseline, Week 4, and Week 8

Secondary outcomes

  1. Change in Parent-Reported Focus

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

  2. Change in Parent-Reported Attention

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

  3. Change in Parent-Reported Sleep Quality

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

  4. Change in Parent-Reported Gut Health

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

  5. Change in Parent-Reported Natural Energy

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

  6. Change in Parent-Reported Overall Well-Being

    Assessed via parent-completed self-reported questionnaire

    Time frame: Baseline, Week 2, Week 4, Week 6, and Week 8

06

Study locations

1 site
  • Citruslabs
    Las Vegas, Nevada 89101, United States
07

Registry details

Key details

Study ID
NCT07766642
Lead sponsor
Auri Nutrition
Collaborators
Citruslabs
Responsible party
Sponsor
First posted
Aug 14, 2026
Start date
Mar 13, 2026
Primary completion
Sep 2026 (estimated)
Completion
Sep 2026 (estimated)
Last update
Aug 14, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion